Tylenol’s Maker Pushes Back Against Possible Label Change. Tylenol’s maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting a potential link between its use during pregnancy and the development of autism or ADHD in children. The company argues that acetaminophen, known as Tylenol, is one of the most studied medicines in history. It states that altering the label based on these findings would be "arbitrary, capricious, and contrary to law." Tylenol, Kenvue's biggest-selling brand, generates about $1 billion annually. The current label advises pregnant or breastfeeding individuals to consult a healthcare professional before use. Kenvue's objection underscores concerns about the broader impact on public perception and potential legal ramifications. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT